193 related articles for article (PubMed ID: 28340014)
21. Apical vs. non-apical right ventricular pacing in cardiac resynchronization therapy: a meta-analysis.
Zografos TA; Siontis KC; Jastrzebski M; Kutyifa V; Klein HU; Zareba W; Katritsis DG
Europace; 2015 Aug; 17(8):1259-66. PubMed ID: 25829472
[TBL] [Abstract][Full Text] [Related]
22. Revisiting diastolic filling time as mechanistic insight for response to cardiac resynchronization therapy.
Verbrugge FH; Verhaert D; Grieten L; Dupont M; Rivero-Ayerza M; De Vusser P; Van Herendael H; Reyskens R; Vandervoort P; Tang WH; Mullens W
Europace; 2013 Dec; 15(12):1747-56. PubMed ID: 23821473
[TBL] [Abstract][Full Text] [Related]
23. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
[TBL] [Abstract][Full Text] [Related]
24. New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade atrioventricular block and normal left ventricular function.
Zhang XH; Chen H; Siu CW; Yiu KH; Chan WS; Lee KL; Chan HW; Lee SW; Fu GS; Lau CP; Tse HF
J Cardiovasc Electrophysiol; 2008 Feb; 19(2):136-41. PubMed ID: 18005026
[TBL] [Abstract][Full Text] [Related]
25. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
[TBL] [Abstract][Full Text] [Related]
26. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
[TBL] [Abstract][Full Text] [Related]
27. Time course of secondary mitral regurgitation in patients with heart failure receiving cardiac resynchronization therapy: Impact on long-term outcome beyond left ventricular reverse remodelling.
Binda C; Menet A; Appert L; Ennezat PV; Delelis F; Castel AL; Le Goffic C; Guyomar Y; Ringlé A; Guerbaai RA; Graux P; Tribouilloy C; Maréchaux S
Arch Cardiovasc Dis; 2018 May; 111(5):320-331. PubMed ID: 29102366
[TBL] [Abstract][Full Text] [Related]
28. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
[TBL] [Abstract][Full Text] [Related]
29. His or para-His pacing preserves left ventricular function in atrioventricular block: a double-blind, randomized, crossover study.
Kronborg MB; Mortensen PT; Poulsen SH; Gerdes JC; Jensen HK; Nielsen JC
Europace; 2014 Aug; 16(8):1189-96. PubMed ID: 24509688
[TBL] [Abstract][Full Text] [Related]
30. Cardiac resynchronization therapy (CRT) with right ventricular sense triggered left ventricular pacing benefits for the hemodynamics compared with standard CRT for chronic congestive heart failure: A cross-over study.
Pu LJ; Wang Y; Zhao L; Luo ZL; Hua BT; Han MH; Li SM; Yang J; Li L; Peng YZ; Guo T
Cardiol J; 2015; 22(1):80-6. PubMed ID: 25179313
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older.
Adelstein EC; Liu J; Jain S; Schwartzman D; Althouse AD; Wang NC; Gorcsan J; Saba S
Europace; 2016 Mar; 18(3):420-7. PubMed ID: 26487669
[TBL] [Abstract][Full Text] [Related]
32. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
[TBL] [Abstract][Full Text] [Related]
34. Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure).
Damy T; Ghio S; Rigby AS; Hittinger L; Jacobs S; Leyva F; Delgado JF; Daubert JC; Gras D; Tavazzi L; Cleland JG
J Am Coll Cardiol; 2013 May; 61(21):2153-60. PubMed ID: 23541971
[TBL] [Abstract][Full Text] [Related]
35. Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes.
Sardu C; Barbieri M; Santamaria M; Giordano V; Sacra C; Paolisso P; Spirito A; Marfella R; Paolisso G; Rizzo MR
Cardiovasc Diabetol; 2017 Jun; 16(1):75. PubMed ID: 28599667
[TBL] [Abstract][Full Text] [Related]
36. Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks.
Van Boven N; Bogaard K; Ruiter J; Kimman G; Theuns D; Kardys I; Umans V
J Cardiovasc Electrophysiol; 2013 Mar; 24(3):316-22. PubMed ID: 23210664
[TBL] [Abstract][Full Text] [Related]
37. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcome of patients with and without super-response to CRT-D.
Franke J; Keppler J; Abadei AK; Bajrovic A; Meme L; Zugck C; Raake PW; Zitron E; Katus HA; Frankenstein L
Clin Res Cardiol; 2016 Apr; 105(4):341-8. PubMed ID: 26497005
[TBL] [Abstract][Full Text] [Related]
39. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates.
Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA
Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384
[TBL] [Abstract][Full Text] [Related]
40. Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate.
Sardu C; Paolisso P; Sacra C; Santamaria M; de Lucia C; Ruocco A; Mauro C; Paolisso G; Rizzo MR; Barbieri M; Marfella R
Cardiovasc Diabetol; 2018 Oct; 17(1):137. PubMed ID: 30348145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
